In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

New York City (NYC) has emerged as one of the epicenters of the current severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first
detected in China and has since caused a pandemic of coronavirus disease 2019 (COVID-19). …

By conducting a retrospective, cross-sectional analysis of SARS-CoV-2 seroprevalence in a
‘sentinel group’ (enriched for SARS-CoV-2 infections) and a ‘screening group’ (…

Highly efficacious vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been developed. However, the emergence of viral variants that are more …

Numerous reports document the spread of SARS-CoV-2, but there is limited information on
its introduction before the identification of a local case. This may lead to incorrect …

As severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infections continue, there
is a substantial need for cost‐effective and large‐scale testing that utilizes specimens that …

The coronavirus disease 2019 (COVID‐19) pandemic has sparked the rapid development
of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostics. However, …

Objective Dual carbapenemase-producing organisms (DCPOs) are an emerging threat that
expands the spectrum of antimicrobial resistance. There is limited literature on the clinical …

Background Certain communities in the United States experience greater opioid-involved
overdose mortality than others. Interventions to stem overdose benefit from contextual …